ISDE食管癌大会内容汇总
Monday, September 26
03:30 PM - 04:30 PM
K01 - Opening Remarks and Keynote Lecture
K01.02 Keynote Lecture Precision and Personalised Oncology for Esophageal Cancer
04:45 PM - 05:45 PM
JS01 - JES Guideline on Oncologic Treatment for Esophageal Cancer (ISDE, JES)
Ken Kato Dr., National Cancer Centre Hospital
JS01.01 - Updates in JES Guidelines on Medical Oncology
JS01.02 - Does Updated JES Guideline Influence on Clinical Practice in Korea?
JS01.03 - Is New JES Guideline Applicable to Clinical Practice in France?
04:45 PM - 06:15 PM
PL01 - Trauma, Caustic Injury and Perforation of the Esophagus
PL01.01 - Endoscopic Treatment and Factors Affecting Mortality of Esophageal Perforation
PL01.02 - Is Surgery Still a Valid Option in the Treatment of Boerhaave's Syndrome?
PL01.03 - Esophageal Stricture After Caustic Injury: Dilatation or Surgery?
PL01.04 - Traumatic Perforation of the Esophagus: Diagnosis and Treatment
PL01.05 - Resection and Reconstruction Techniques After Caustic Injury to the Esophagus
PL02 - Early Esophageal Cancer: Epidemiology, Methods of Detection and Endoscopic Staging
Rebecca Fitzgerald Yin-Kai Chao
PL02.02 - Identification of High-risk Cohorts: Screening, Breath Test, Cytosponge and Methods for Early Diagnosis
PL02.03 - Screening Programs in High-incidence Regions, ALDH2 in Asia
PL02.04 - Techniques in Endoscopic Early Detection of Esophageal Neoplasm
PL02.05 - Endoscopic Resection as Staging Procedure for Early Esophageal Cancer
OA01.01 - Laparoscopic Total Fundoplication is Superior to Medical Treatment for Reducing the Cancer Risk in Barrett's Esophagus: a Long-term Analysis
OA01.02 - Endoscopic Reference Score Remodeling Subscore and Esophageal Eosinophil Count Do Not Correlate in Placebo-Treated Eosinophilic Esophagitis Patients From Dupilumab Studies
OA01.03 - Laparoscopic Cardioplasty for Failed Primary Treatment of Achalasia
OA01.04 - Operative Outcomes of Robotic Gastropexy in the Treatment of Giant Paraesophageal Hernia in Patients with Predominantly Obstructive Symptoms
OA01.06 - Oesophageal Perforations: Causes, Management, and Outcomes at a Specialist Upper Gastrointestinal Unit over a Ten-year Period
OA01.07 - Does Postoperative Non-Invasive Ventilation Increase the Risk for Complications in Children Post-Repair of Esophageal Atresia?
OA01.08 - Role of Preoperative Neoadjuvant Chemoradiotherapy for Locally Advanced Borderline Resectable Thoracic Esophageal Cancer
OA01.09 - Risk Factors Associated with Not Receiving Adjuvant Chemotherapy for Locally Advanced Esophagogastric Adenocarcinoma
05:45 PM - 06:45 PM
VA01.01 - Thoraco-Laparoscopic Excision of a Foregut Duplication Cyst with a Pyloro-duodenal Communication
VA01.02 - Alport Syndrome with Esophageal Leiomyoma Treated with Conservative Distal Robotic Myotomy: Avoiding Esophagectomy?
VA01.03 - Epiphrenic Diverticulum Causing Gastroesophageal Junction Outflow Obstruction (EGJOO)
VA01.04 - Redo Laparoscopic Heller’s Cardiomyotomy
VA01.05 - Thoracoscopic Enucleation of Giant Oesophageal Leiomyoma
VA01.06 - Thoracolaparoscopic Excision of Esophageal Duplication Cyst
VA01.07 - VATS Esophageal Diverticulectomy with Laparoscopic Heller Myotomy and Dor Fundoplication
VA01.09 - Management of Intraoperative Tracheal Tear during Esophagectomy
Subramanyeshwar Rao Thammineedi
VA01.08 - Robotic Esophageal Leiomyoma Enucleation
JS02 - JES Guideline on Endoscopic Treatment for Esophageal Cancer (ISDE, JES)
06:30 PM - 08:00 PM
JS02.01 - Updates in JES Guideline on Endoscopic Treatment for Esophageal Cancer
JS02.02 - Is New JES Guideline Applicable to Endoscopic Treatment in Hong Kong?
JS02.03 - Esophageal Submucosal Adenocarcinoma: Work-up and Post-endoscopic Resection Management
PL03 - The Tapestry of Reflux Syndromes
PL03.01 - Cost-effective Diagnosis of GERD
PL03.02 - Diagnosis of Symptomatic Non-acidic Gastroesophageal Reflux
PL03.03 - Reflux in the Obese and Post-bariatric Procedures
PL03.04 - GERD in East and West - Is There a Difference in Management?
PL03.05 - Surgical Treatment of GERD, Fundoplication and Other Techniques - the Right Procedure for the Right Patient
PL04 - Recent Topics in Endoscopic Treatment for Esophageal Cancer
PL04.01 - Extended Indications for Endoscopic Resection of Adenocarcinoma
PL04.02 - Ablation and Surveillance of pT1b Patients Treated With Endoscopic Resection
PL04.03 - Barrett’s Neoplasia: New Treatment Modalities
PL04.04 - Use of Stent Before Curative Esophagectomy: Should This Be Done?
PL04.05 - Prevention of Stricture after ED for Widespread ESCC
OA02.02 - The Modality of Neoadjuvant Versus Adjuvant Chemoradiotherapy for Locally Advanced Esophageal. Carcinoma: A Single Center, Randomized, Clinical Trial
OA02.03 - Assessment of Tumor Regression Grade in Esophageal Squamous Cell Carcinoma After Chemoradiotherapy: Comparison of 3 Commonly Used Scoring Systems
OA02.05 - The Primary Tumor Burden Score: A Novel Clinicopathological Staging Tool for Patients with Esophageal Carcinoma Receivnig Neoadjuvant Chemoradiotherapy Plus Surgery
OA02.06 - Radiofrequency Ablation of Low-Grade Dysplasia is Cost-Effective for Patients with Long-Segment Barrett's Oesophagus
OA02.07 - Do Patients with "Early" Esophageal Cancer Need Neoadjuvant Therapy?
OA02.08 - Clonal Relationship and Alcohol Consumption-Associated Mutational Signature in Synchronous Hypopharyngeal Tumors and Esophageal Squamous Cell Carcinoma
OA02.09 - Surgical Treatment of Stage IV Esophageal Cancer after CCRT Improves Survival
07:00 PM - 08:00 PM
OA03.01 - Clinical Utility of ctDNA in Longitudinal Monitoring of Treatment Responses and Relapse in Metastatic Esophageal Squamous Cell Carcinoma
OA03.02 - Outcome of Esophageal Resection in Patients with Esophageal Cancer with Histopathologically Confirmed Distant Metastasis
OA03.03 - Clinical Outcome of Nivolumab Combination Therapy As 1st Line Treatment for Esophageal Cancer in a Japanese Hospital (CheckMate 648)
OA03.04 - Diversity of Perineural Invasion and Their Predictive Role in Prognosis of Esophageal Squamous Cell Carcinoma
OA03.05 - Molecular Subtyping of Esophageal Adenocarcinoma by Non-negative Matrix Factorization of Laser Capture Microdissected RNA-Seq Samples
OA03.06 - Establishing a Mass Spectrometry Based Diagnostic Test for Oesophageal Cancer
OA03.07 - The Prognostic Effect of Pathological Lymph Node Regression after Neoadjuvant Chemotherapy for Oesophageal Adenocarcinoma – a Multicentre Study
OA03.08 - Genomic Alterations and Survival After Treatment of EAC by Surgery Without Chemo- or Radiotherapy
OA03.09 - The Effectivity of Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma with Presence of Extracellular Mucine, Signet-ring Cells or Poorly Cohesive Cells
JS03 - JES Guideline on Surgical Treatment for Esophageal Cancer (ISDE, JES)
08:15 PM - 09:45 PM
JS03.01 - Updates in JES Guidelines on Surgical/Perioperative Treatment
JS03.02 - Does Updated JES Guideline Influence on Clinical Practice in Hong Kong?
JS03.03 - Is New JES Guideline Applicable to Clinical Practice in the United States?
PL05 - Functional Complications After Esophageal Surgery
PL05.01 - Gas-bloat Syndrome After Antireflux Surgery
PL05.02 - Transition to Adult Care After Treatment for Esophageal Atresia
PL05.03 - Strictures After Esophagectomy With Gastric Pull-up
PL05.04 - Delayed Gastric Emptying After Esophagectomy
PL05.05 - Barrett's Esophagus After Esophagectomy: a Cause for Concern?
PL06 - Surgical Approach for Esophageal and EGJ Tumors
Richard van Hillegersberg Suzanne Gisbertz
PL06.01 - EGJ Tumors: Optimal Surgery in the East
PL06.02 - EGJ Tumors: Optimal Surgery in the West
PL06.03 - Paraaortic Lymph Node Dissection for Siewert Type II and III EGJ Tumors
PL06.04 - Current Evidence and/or Ongoing RCT of Minimal Invasive Esophagectomy for Cancer
PL06.05 - Does MIE Affect the Prognosis of Esophageal Cancer
VS01 - Minimally Invasive Approach to Esophagectomy
VS01.01 - Uniportal Esophagectomy
VS01.02 - Trans-mediastinoscopic Esophagectomy
VS01.03 - Robotic Esophagectomy
VS01.04 - Robotic Transhiatal Dissection
VS01.05 - VATS Esophagectomy in Semi-prone Position
VS01.06 - Thoracoscopic Esophagectomy With Radical Lymphadenectomy
FA01.01 - Refusing Surgery After Neoadjuvant Treatment in Patients With Esophageal Cancer: A Propensity-Score Matched Survival Analysis
FA01.02 - Malnutrition Defined by GLIM Criteria Associates With Increased Risk of Adverse Outcome After Oesophago-Gastric Cancer Surgery
FA01.03 - Long Term Risk for Progression to Neoplasia for Barrett’s Esophagus Patients With Validated Low-grade Dysplasia or Indefinite for Dysplasia
FA01.04 - Phase III Comparative Study of Preoperative Treatment of Esophageal Cancer (JCOG1109) – Site of Recurrence and Prognosis of non-pCR Patients
FA01.06 - Outcomes of Adjuvant Local Treatment after Esophageal Surgery with Positive Resection Margin in Intrathoracic Anastomosis
FA01.08 - The Associated Risk Between Single Nucleotide Polymorphisms of AP1S1 and Esophageal Squamous Cell Carcinoma in Chinese Population
FA01.09 - Outcome of Neoadjuvant Chemoradiotherapy plus Surgery for Esophageal Squamous Cell Carcinoma in East Asia versus Western Europe
10:00 PM - 11:30 PM
OA04.01 - The Prognostic Value and Molecular Properties of Tertiary Lymphoid Structures in Esophageal Squamous Cell Carcinoma
OA04.02 - The Prognostic Impact of Tumor Budding in Esophageal Adenocarcinoma
OA04.05 - FDG PT-CT Metabolic Tumour and Nodal Response as a Predictor of Pathological Response and Survival in Patients with Oesophageal Adenocarcinoma
OA04.06 - The Need for Information and Support in Decision-making in Patients with Esophageal Cancer who Prefer Standard Surgery or Active Surveillance
OA04.07 - Surgeon’s Behavior Steering Patients to Participate in a Cluster Randomized Trial on Active Surveillance for Esophageal Cancer
OA04.09 - Endoscopic Scoring System for Achalasia Pre and Post Lower Esophageal Sphincter Intervention: The Delayed Esophageal Clearance in Achalasia (Deca) Score
PL07 - Debates in Controversies in Esophageal Cancer
PL07.01 - Thoracic Duct Resection in Esophagectomy: Should It Be Done? - Pro
PL07.02 - Thoracic Duct Resection in Esophagectomy: Should It Be Done? - Con
PL07.03 - Does Surgery Have a Role in T4 Disease for Esophageal Cancer? - Pro
PL07.04 - Does Surgery Have a Role in T4 Disease for Esophageal Cancer? - Con
PL07.05 - Can Definitive CRT Replace Esophagectomy? - Pro
PL07.06 - Can Definitive CRT Replace Esophagectomy? - Con
PL07.07 - Neoadjuvant Chemoradiotherapy Is Optimum Standard for Esophageal Adenocarcinoma - Pro
PL07.08 - Neoadjuvant Chemoradiotherapy Is Optimum Standard for Esophageal Adenocarcinoma - Con
Riccardo Rosati Wayne Hofstetter
VS02.01 - Prevention and Treatment of Anastomotic Leak With Endosponge
VS02.02 - Colonic Interposition
VS02.03 - Robotic Recurrent Laryngeal Nerve Lymphadenectomy
VS02.04 - Esophageal ESD Tips and Tricks
VS02.05 - Supercharged Jejunum Replacement of the Esophagus
VS02.06 - Endoscopic Treatment of Esophageal Diverticulum
VS02.07 - Hybrid Prone-left Lateral Position Esophagectomy With VATS Intrathoracic Anastomosis
VS02.08 - Hybrid Esophagectomy With Open Thoracotomy
VS02.09 - Minimally Invasive Ivor Lewis Esophagectomy in Lateral Position
Inderpal Sarkaria Wen-Tao Fang
FA02.01 - The Effect of Enhanced Recovery After Minimally Invasive Esophagectomy: A Randomized Controlled Trial
FA02.02 - Comparison of Robotic Assisted Minimally Invasive Esophagectomy vs. Minimally Invasive Esophagectomy: A Propensity Matched Study from a Single High-Volume Institution
FA02.03 - Does Minimally Invasive Esophagectomy Reduce Postoperative Pulmonary Complications? An International Cohort Study from the Oesophagogastric Anastomosis Audit (OGAA)
FA02.04 - Differences in Perioperative Strategies in Esophageal Cancer Treatment in 13 Nordic University Hospitals Call for High-level Evidence Regarding These Practices
FA02.05 - Genomic Analysis of Response to Neoadjuvant Chemotherapy in Oesophageal Adenocarcinoma
FA02.06 - Prediction of Lymph Node Metastasis in Patients With Esophageal Squamous Cell Carcinoma Using Genetic Signatures From Large-Scale Genomic Repertoires
FA02.07 - Extension of FDG-PET-Based Radiomic Models on Identification of Patients With Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy
FA02.08 - Toripalimab Combination With Chemotherapy and Subsequent Radiation in Patients With Stage IV Esophageal Carcinoma，a Prospective Phase II Study (TR-EAT Trial)
FA02.09 - Mapping of Lymph Node Metastasis From Thoracic Esophageal Cancer: A Retrospective Study
OA05.01 - Surgery Versus Non-surgical Treatment for Thoracic Esophageal Cancer in Patients Older Than 70 Years: A Retrospective Analysis of 749 Cases
OA05.02 - Does Chest Pain Affect the Long Term Outcome of Surgery for Esophageal Achalasia?
OA05.03 - Esophageal Achalasia: Very Long Follow-up Study on Patterns and Complications of Post Myotomy GERD
OA05.04 - The Tumour Immune Microenvironment in Oesophageal Adenocarcinoma Has Prognostic Significance
OA05.05 - Robot-assisted Minimally Invasive Thoraco-laparoscopic Esophagectomy versus Minimally Invasive Esophagectomy for Resectable Esophageal Adenocarcinoma: A Randomized Controlled Trial (ROBOT-2-trial)
OA05.06 - Esophagogastric Junction Cancer: A Difficult Border: A Worldwide Survey on Oncological and Surgical Approach
OA05.07 - Enhanced Recovery after Surgery for Video-Assisted Thoracoscopic (VATS) Esophagectomy- A propensity score matching analysis in a local institute
OA05.08 - Left Thoracophrenotomy Oesophagogastrectomy as an Alternative Approach in Oesophageal Cancer
OA05.09 - Robotic-assisted Minimally Invasive Esophagectomy (RAMIE): Is This the Way to a More Accurate Thoracic Lymphadenectomy?
OA06.01 - Automated Surgical Step Recognition for Robot-Assisted Minimally Invasive Esophagectomy Using Artificial Intelligence
OA06.02 - Outcomes after Robot-assisted Minimally Invasive Esophagectomy: Review of 1000 Patients in a Single Center
OA06.03 - Value of Extended and Total Mediastinal Lymphadenectomy in Esophageal Tumors
OA06.04 - Modified en bloc Esophagectomy with Total Lymphadenectomy in Patients with Residual Rumor after Neoadjuvant Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
OA06.05 - Competency Assessment Tool for Minimally Invasive Esophagectomy: Development, Construct Validity, Reliability and Version 2
OA06.06 - Incidence and Impact of Preoperative Hiatal Hernia in Patients with Esophageal Carcinoma Undergoing Curative Surgical Resection
OA06.07 - Short-term Clinical Effect of Robot-assisted Esophagectomy with Thoracic Duct Resection
OA06.08 - The Impact of Overall Survival on Two-field or Three-field Lymphadenectomy in Middle and Lower Thoracic Esophageal Squamous Cell Carcinoma
OA06.09 - Propensity Score-matched Comparison of Outcomes between Posterior Mediastinal and Retrosternal Routes of Reconstruction following Three-phase Esophagectomy
Tuesday, September 27
06:30 PM - 08:00 PM
CSDE - What are the Optimal Treatment Regimens for Esophageal Cancer
Long-Qi Chen Mark Ferguson Zhen-Tao Yu
CSDE.01 - Introduction from Prof. He, Honorary President of CSDE
CSDE.02 - What is the Best Strategy for Esophageal Cancer in China: Screening, Early Diagnosis, and Treatment
CSDE.03 - The Changes in the Surgical Treatment for Esophageal Cancer in China
CSDE.04 - Can the Robotic Approach Improve Patient’s Survival in Surgical Treatment of Esophageal Cancer? Mid-term Results of RAMIE Trial
CSDE.05 - Definitive Chemoradiotherapy for Advanced Esophageal Squamous Cell Carcinoma - Results from Multiple Centers in China
CSDE.06 - A Phase II Clinical Trial of Toripalimab Combined with Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (NEOCRTEC1901)
Jun-Feng Liu Ke-Neng Chen Wen-Tao Fang Yin Li
PL08 - Complications After Esophagectomy
Paul Magnus Schneider Simon Law
PL08.01 - Chylothorax: Definition and Evidence-based Treatment
PL08.02 - Roux-en-y Duodenal Diversion for Prevention and Treatment of Delayed Gastric Emptying Following Esophagectomy
PL08.03 - Bowel Herniation After Esophagectomy: a Specific Problem of MIE - Prevention and Treatment
PL08.04 - Anastomotic Leakage and Gastric Conduit Necrosis
PL08.05 - Recurrent Laryngeal Nerve Injury: Prevention and Management
PL08.06 - International ESODATA Experience: What Do We Know, Where Do We Go?
PL09 - What is New in Translational Oncology in Esophageal Cancer
PL09.01 - Scientific Insights Into Tumor Microenvironment: Implications for Therapy
PL09.02 - Radiation Therapy: New Vistas Incorporating Metabolic Response and Immune Cell Modulation in Multimodal Therapy
PL09.03 - Role of Patient-derived Organoids in Tailoring Neoadjuvant Therapy
PL09.04 - Circulating Tumor DNA: Current Status, Is It Ready to Change the Paradigm?
PL09.05 - Genomics of Esophageal Cancer: Current Status and Future Prospects
OA07.02 - Evaluation of Subcarinal Lymph Node Dissection and Metastasis in Transmediastinal Radical Esophagectomy
OA07.01 - Robot-assisted and Conventional Minimally Invasive Esophagectomy are Associated with Better Postoperative Results Compared to Hybrid and Open Transthoracic Esophagectomy
OA07.03 - Clinical Outcomes of Esophagectomy in Advanced Age Patients – A Propensity Score Matching Study in a Local Institute
OA07.04 - Perioperative Morbidity and Mortality after Standard Two-field and Radical Three-field Esophagectomy – Results from a Randomized Trial
OA07.05 - Near-infrared Fluorescence Imaging of Thoracic Duct in Minimally Invasive Esophagectomy
OA07.06 - Analytic Morphomic Index and Quantitative Gastric Perfusion Assessment for Risk Stratification of Anastomotic Leaks following Esophagectomy
OA07.07 - Determining Severity of Esophageal Anastomotic Leak in Patients After Esophagectomy: Development of the SEAL Score
OA07.08 - Implementation of the Esophagectomy Complications Consensus Group Definitions: The Benefits of Speaking the Same Language
OA07.09 - The Risk Factors of Hiatal Hernia in Esophageal Cancer Patients Who Received Gastric Interposition Through Posterior Mediastinal Route
08:15 PM - 09:45 PM
VA02.01 - How to Do It? Supracarinal Approach of the Left Recurrent Laryngeal Nerve Area for Lymphadenectomy During Thoracoscopic Esophagectomy
VA02.04 - Oesophagectomy With Roux-en-Y Double-Tract Recontruction for Distal Oesophageal Cancer
VA02.05 - Fully Robotic Ivor-Lewis Esophageal Resection (RAMIE) – Technical Details of the RAMIE Procedure in the ROBOT2 Trial
VA02.06 - Video Assisted Thoracoscopic Esophagectomy with Aberrant Vascular Anatomy
VA02.07 - Manual Layer Embedded Anastomosis: A New Technique to Reduce Anastomosis Leakage after Esophagectomy
VA02.09 - Preventing Esophago-gastric Anastomotic Leaks; The Role of Load-Bearing Sutures
PL10 - The Cutting Edge in Reflux and Barrett's Esophagus
PL10.01 - Diagnosis and Treatment of Refractory GERD
PL10.02 - Novel Endoscopic Treatment of GERD: ARMA, POEF and Others
PL10.03 - Approaches to Esophageal Lengthening: When, How, and Outcomes
PL10.04 - What to Do for Dysphagia and Return of Reflux After Fundoplication
PL10.05 - Endoscopic Management of Benign Recalcitrant Stricture
PL11 - Immuno-oncology, Targeted Therapies in Treatment of Esophageal Cancer
Florian Lordick Satoru Matsuda
PL11.01 - Has Immunotherapy Changed the Clinical Landscape of ESCC
PL11.02 - Neoadjuvant Immunotherapy for Esophageal and Esophago-gastric Junction Adenocarcinoma: Scientific Rationale, Current Evidence, and Clinical Trials
PL11.03 - Role of Surgery in Oligometastatic Disease of EGJ Cancer: the Renaissance Trial
PL11.04 - Molecular Targeted Therapies: Current Status
PL11.05 - What Is the Appropriate Radiation Field in Esophageal Cancer Treatment?
VS03 - GERD, Barrett's Esophagus and Benign Pathologies
VS03.01 - TIFF Procedure Dos and Don’ts
VS03.02 - Giant Hiatal Hernia Repair
VS03.03 - Redo Surgery for GERD
VS03.04 - Submucosal Tunnel Endoscopic Resection of Benign Esophageal Lesions
VS03.05 - Endoscopic Incision Therapy for Benign Esophageal Stricture
VS03.06 - Magnifying Endoscopic Diagnosis With NBI or BLI for Barrett's Esophagus
FA03.01 - Pre-existing Mesh At The Hiatus Increases Morbidity During And After Revisional Antireflux Surgery: A National Cohort Study
FA03.02 - Different Clinical Symptom Patterns in Patients With Reflux Micro-Aspiration Confirmed by New Pulmonary Aspiration Scintigraphy Technique
FA03.03 - Anti-reflux Radiofrequency Therapy Using STRETTA for Refractory GORD Is Feasible and Reduces the Need for Minimally Invasive Surgery
FA03.04 - Laparoscopic Fundoplication Effective in Treating Reflux Micro-Aspiration
FA03.05 - Local Inflammatory Response to Gastroesophageal Reflux: Association of Gene Expression of Inflammatory Cytokines With Multichannel Intraluminal pH-Impedance Data
FA03.06 - Endoscopic Vacuum Therapy for Patients With Esophageal Perforation: A Multi-Center Retrospective Cohort Study
FA03.07 - Esophageal Perforations – A Population-Based Nationwide Study in Sweden With Survival Analysis
FA03.08 - Intentional Foreign Body Ingestion Among Adults: An Updated 2022 Systematic Review of Case Report Outcomes and Implications for Endoscopic Management
FA03.09 - New Endoscopic Treatment Technique to Prevent Refractory Corrosive Esophageal Strictures
10:00 PM - 10:45 PM
OA08.01 - Outcome Following Minimal Invasive Versus Open Esophagectomy for Esophageal Carcinoma Patients With Liver Cirrhosis: A Propensity Score-Matched Analysis
OA08.02 - Major Intraoperative Complications in Minimally Invasive Esophagectomies
OA08.03 - Quantitative Estimation of Gastric Conduit Perfusion to Select Esophagectomy Patients at High Risk of Impaired Perfusion
OA08.04 - Minimally Invasive Cervical Esophagectomy (MICE): First Results of a Dutch Pilot Study
OA08.05 - Frailty as a Predictor of Postoperative Complications in Patients Undergoing Esophagectomy
OA08.06 - Evaluation of the Results of “Tubeless” Esophagectomy in Patients With Esophageal Cancer Within an ERAS Protocol
OA08.07 - Risk Factors of Delayed Gastric Emptying after Esophagectomy with Gastric Interposition: An Analysis of 810 Cases
OA08.08 - Robotic Versus Thoracolaparoscopic Esophagectomy for Carcinoma Esophagus: A Prospective Comparative Study of Pathological Radicality and Short Term Outcomes
OA08.09 - Clinical Implications of Chyle Leakage Following Esophagectomy
Population Screening for Esophageal Cancer. How Can We Make It Work?
11:00 PM - 11:59 PM
John Reynolds Richard van Hillegersberg
ESDE.01 - Definition and Overview of Oligometastatic Disease in Esophageal Cancer
ESDE.02 - Oligometastatic Disease in the Era of Immunotherapy and Precision Medicine
ESDE.03 - SBRT and Local Ablative Techniques for Oligometastatic Disease
PL12 - New Insights into Achalasia (part 1)
Arjan Bredenoord Hironari Shiwaku
PL12.01 - Diagnosis of Achalasia According to Chicago 4.0
PL12.02 - Pneumatic Dilation, POEM or Heller's Myotomy?
PL12.03 - Treatment of Achalasia in Children
FA04 - Featured Abstracts 4 (part 1)
FA04.01 - Superior Mediastinal Dissection During Minimally Invasive Esophagectomy for Esophageal Cancer – A Multicenter Propensity Score Matched (PSM) Analysis
FA04.02 - Favorable Outcomes of Jejunal Interposition Reconstruction Without Vascular Anastomosis After Esophagectomy for Cancer: A Single-Center Experience Over Two Decades
FA04.03 - The Effectiveness of Telephone and Internet-Based Supportive Care for Patients With Esophageal Cancer on Enhanced Recovery After Surgery in China
FA04.04 - Treatment of Anastomotic Leak After Esophagectomy (TENTACLE– Esophagus) Study: Efficacy of Different Initial Treatment Strategies for Anastomotic Leak
FA04.06 - Indocyanine Green Fluorescence Angiography versus Visual Assessment for Gastric Conduit Perfusion Assessment in Patients undergoing Esophagectomy: A Randomized Controlled Study
Subramanyeshwar Rao Thammineedi
OA09 - Oral Abstracts 9 (part 1)
OA09.01 - The Role of Early Mobilization After Esophageal Cancer Surgery
OA09.02 - Impact of Surgery Start Time on Short Term Outcomes of Elective Esophagectomy for Cancer
OA09.03 - Sarcopenia After Neoadjuvant Chemotherapy Is Associated With Development of Moderate to Severe Post-Operative Complications in Esophagogastric Adenocarcinoma Patients
OA09.04 - Textbook Outcomes for Oesophagectomy: An Evaluation of Oesophagectomy Quality Performance Indicators at a Single High-Volume Australian Oesophagogastric Centre
OA09.05 - Does MIE Reduce Pulmonary Complications in a Real-world Scenario?
OA10 - Oral Abstracts 10 (part 1)
OA10.01 - Long Term Results of Single and Multi-Incision Minimally Invasive Esophagectomy (MIE) for Treating Esophageal Cancer: A Propensity Score Matched Study
OA10.02 - Survival Impact of Clinical and Nonclinical Reasons for Delay to Esophagectomy after Neoadjuvant CROSS Therapy
OA10.03 - A Nomogram Based on Body Mass Index Changes to Predict Prognosis After Curative Resection of Esophageal Squamous Cell Carcinoma
OA10.04 - Exploring the Optimal Starting Age for Esophageal Cancer Screening Based on Data From a Multicenter Populations-Based Cohort and Cancer Registry
OA10.05 - Role of Thoracoscopic Hand-sewn Esophago-gastric Anastomosis in 2-stage Totally Minimally Invasive Esophagectomy. Report of 200 Consecutive Cases
OA10.06 - Salvage Surgery for Esophageal Cancer: Is It Time To Refine Surveillance Criteria?
Wednesday, September 28
12:00 AM - 12:30 AM
John Reynolds Richard van Hillegersberg
ESDE.04 - Surgery for Oligometastatic Disease
PL12 - New Insights into Achalasia (part 2)
Arjan Bredenoord Hironari Shiwaku
PL12.04 - Management of Reflux After Achalasia Treatment
PL12.05 - Recurrent Achalasia After POEM and Heller's Myotomy
FA04 - Featured Abstracts 4 (part 2)
FA04.07 - A 10-year Experience With Anastomotic Leaks in Upper Gastrointestinal Surgery
FA04.08 - Postoperative Outcomes of Salvage Esophagectomy After Definitive Chemoradiotherapy and Planned Esophagectomy After Neoadjuvant Chemoradiotherapy
FA04.09 - Omission of Routine Pyloric Procedures in Minimally Invasive Esophagectomy: What Is the Impact on Peri-Operative Outcomes?
OA09 - Oral Abstracts 9 (part 2)
OA09.07 - Prognostic Comparison of Lymphovascular Invasion and Lymph Node Metastasis in Esophageal Cancer Patients
OA09.08 - Impact of Weekend Effect on Short- and Long-term Survival of Patients Undergoing Esophagectomy for Cancer: A Population-Based, Propensity Score-Matched Analysis
OA09.09 - Long-Term Quality of Life After Minimally Invasive Esophagectomy for Esophageal Cancer: A Single Center Experience
OA10 - Oral Abstracts 10 (part 2)
10:00 PM - 11:30 PM
OA10.07 - Real-time Novel Oxygen Saturation Imaging Device to Evaluate the Optimal Anastomotic Site During Thoracic Esophagectomy
OA10.08 - Single-Port Mediastinoscopic Lymphadenectomy in the Upper and Middle Mediastinum Using Continuous Intraoperative Nerve Monitoring
OA10.09 - The Utility of Tissue Oxygen Saturation During Gastric Tube Reconstruction With Cervical Anastomosis for Esophagectomy
DOTE.01 - Short- and Mid-Term Outcomes of Robotic Versus Thoraco-Laparoscopic McKeown Esophagectomy for Squamous Cell Esophageal Cancer: A Propensity Score-Matched Study
DOTE.02 - Routine Placement of Feeding Jejunostomy Tube During Esophagectomy Increases Postoperative Complications and Does Not Improve Postoperative Malnutrition
DOTE.03 - Improved Barrett’s Neoplasia Detection Using Computer-Assisted Multiframe Analysis of Volumetric Laser Endomicroscopy
DOTE.04 - Esophageal Oncologic Surgery in SARS-CoV-2 (COVID-19) Emergency
DOTE.05 - Transition From Video-Assisted Thoracoscopic to Robotic Esophagectomy: A Single Surgeon’s Experience
DOTE.06 - Persistent Confirmed Low-grade Dysplasia in Barrett's Esophagus Is a Risk Factor for Progression to High-grade Dysplasia and Adenocarcinoma in a US Veterans' Cohort
PL13 - Updated Guidelines and Staging for Esophageal Cancer
PL13.01 - JES Surgical Guidelines for Locally Advanced ESCC: Contrasting Upfront Surgery With Neoadjuvant Therapy
PL13.02 - ESMO Guidelines for Locally Advanced Adenocarcinoma: When Should We Use Chemotherapy Versus Chemoradiation as Preoperative Therapy?
PL13.03 - Staging for Esophageal Cancer After Neoadjuvant Treatment: Is It Accurate and What Are the Best Parameters?
PL13.04 - TNM Staging for EGJ Tumors: Esophageal or Gastric, or Does It Matter?
PL13.05 - The TIGER Study: Time to Standardize Lymphadenectomy for Esophageal Cancer
PL14 - Eosinophilic Esophagitis and Dysphagia
PL14.01 - Diagnosis of EoE: Symptoms, Endoscopy, Histology
PL14.02 - Pathophysiology and Epidemiology: Why Is EoE Rare in the East?
PL14.03 - Medical Treatment Of Eosinophilic Esophagitis and Dysphagia: Current and Future Treatments
PL14.04 - Complications Of Eosinophilic Esophagitis and Dysphagia: Perforation, Stenosis and Food Impactions
PL14.05 - Is There an Overlap Between EoE and GERD?
FA05.01 - Impact of Time to Surgery After Chemoradiotherapy on Tumor Regression and Survival in the Multicenter Randomized Controlled NeoRes II Trial
FA05.02 - Survival Differences According to the Pathologic Status After Neoadjuvant Therapy Followed by Surgery in Esophageal Squamous Cell Carcinoma
FA05.03 - Detection of Molecular Residual Disease (MRD) Using Matched Tumor-margin Sequencing in Early Stage Esophageal Squamous Cell Carcinoma
FA05.04 - Patterns of Recurrent Disease after Neoadjuvant Chemoradiotherapy and Esophageal Cancer Surgery with Curative Intent
FA05.05 - Intratumoral Microbiome Impacts Immune Infiltrates in Tumor Microenvironment and Predicts Prognosis in Esophageal Squamous Cell Carcinoma Patients
FA05.06 - Recurrent Disease After Esophageal Cancer Surgery; a Substudy of the Dutch Nationwide Ivory Study
FA05.07 - Micronutrient Deficiencies after Gastroesophageal Cancer Surgery
FA05.09 - Totally Minimally Invasive 2-stage Esophagectomy versus Hybrid 2-stage Esophagectomy. A Single Center Experience
11:45 PM - 11:59 PM
VA03.02 - Bilateral Vocal Cord Paralysis After Hypopharyngeal Cervical Esophageal ESD – An Unrecognised Rare Complication
VA03.03 - Laparoscopic Re Do Fundoplication
VA03.04 - Oesophago-gastric Junction-plasty: Paraesophageal Hernia Repair + Anti Reflux Surgery Revisited
VA03.05 - Utility of Endoluminal Functional Lumen Imaging in Diagnosis of Esophageal Dysfunction Following Bariatric Surgery
VA03.06 - Laparoscopic Repair of Esophageal Perforation
VA03.08 - Thoracolaparoscopic Management of Esophageal Perforations
VA03.09 - ICG Guided Thoracic Duct Clipping for Chyle Leaks
PL16 - Multidisciplinary Approaches and Perioperative Care of Esophagectomy (part 1)
PL16.01 - Detection of Residual Disease After Chemoradiotherapy; Results From European Pre-SANO (and SANO) Trial
PL15 - How to Find and Treat Neoplastic Barrett's Esophagus (part 1)
Jacques Bergman Sheila Krishnadath
PL15.01 - Defining Cancer Risk in Barrett’s Esophagus: Molecular or Expert Pathology
VS04 - Endoscopic, Surgical Resection Methods and Lymph Node Dissection (part 1)
VS04.01 - Intensive Mediastinal Lymph Node Dissection by VATS and RATS for Esophageal Cancer
FA06 - Featured Abstracts 6 (part 1)
FA06.02 - Patient-Derived Esophageal Adenocarcinoma Organoids Treated With Chemotherapeutic Agents May Predict Tumor Response In Vivo
FA06.03 - Postoperative Chemoradiation for Local Advanced Esophageal Squamous Cell Carcinoma With Low Mean Platelet Volume
OA11 - Oral Abstracts 11 (part 1)
OA11.01 - Perioperative Outcome and Surgical Technique of Transmediastinal Esophagectomy for Esophagogastric Junction Cancer
OA11.02 - The Role of Intraoperative Hyperspectral Imaging (HSI) in the Case of Using Colon Interposition after Oesophagectomy
OA11.03 - Results Comparing SAFE (Supercharged Cervical Anastomosis For Esophagectomy and Gastric Pull-up) and non-SAFE Procedure: Propensed Matched Score Study
OA11.04 - Esophagectomy for Esophageal and Gastroesophageal Junction Adenocarcinoma in RYGB Patients. A Literature Review on Operative Techniques, Safety and Oncologic Outcome
OA11.05 - Uniportal VATS McKeown Esophagectomy: 4-year Experience from a Tertiary Care Center
OA11.06 - Incidence of Reactive Hypoglycaemia in Disease Free Post-oesophagectomy Cohort
Thursday, September 29
12:00 AM - 01:15 AM
PL15 - How to Find and Treat Neoplastic Barrett's Esophagus (part 2)
Jacques Bergman Sheila Krishnadath
PL15.02 - Are There Any Agents to Prevent Progression in Barrett’s Esophagus
PL15.03 - Endoscopic Therapy for Barrett’s Esophagus: When to Resect, When to Burn?
PL15.04 - What to Do When EMR Leaves Positive Margins: ESD or Full Thickness Resection?
PL15.05 - Artificial Intelligence in Barrett’s Esophagus
VS04 - Endoscopic, Surgical Resection Methods and Lymph Node Dissection (part 2)
VS04.02 - Hybrid Esophagectomy With Intraoperative Hyperspectral Imaging
VS04.03 - Precise Mediastinal Lymph Node Dissection for Esophageal Cancer
VS04.04 - Full Thickness Endoscopic Resection for Barrett's Cancer
VS04.05 - Tunneled Esophageal ESD
VS04.06 - Anastomotic/Reconstruction Techniques for Esophagectomy
FA06 - Featured Abstracts 6 (part 2)
FA06.04 - A Validated Nomogram Predicting Lymph Node Metastasis of T2N0 Esophageal Squamous Cell Carcinoma for Clinical Decision-Making
FA06.05 - Neoadjuvant Carboplatin/Paclitaxel Versus 5-Fluorouracil/Cisplatin in Combination With Radiotherapy for Esophageal Squamous Cell Carcinoma: A Multicenter Comparative Study
FA06.06 - Th1 Cell Is the Key Immune-associated Predictor of Pathological Complete Response Following Neoadjuvant Chemoradiation for Esophageal Squamous Cell Carcinoma
FA06.07 - Sonic Hedgehog Positive Expression is Associated with Prognosis and the Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant Chemotherapy
FA06.08 - Comparison of Recurrence Patterns and Survival after Neoadjuvant Chemoradiotherapy vs. Chemotherapy for Esophageal Cancer, a Multi-center European Cohort Study
FA06.09 - Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Esophageal Squamous Cell Carcinoma
OA11 - Oral Abstracts 11 (part 2)
OA11.07 - Effect of Endoluminal Vacuum Therapy on the Perfusion of Gastric Conduit in a Porcine Model for Esophagectomy
OA11.08 - Differences in Multidisciplinary Team Assessment on Esophageal Cancer Patients in Sweden – A Multicentre Study
OA11.09 - Double Lumen Jejunal Free Flap Reconstruction after Proximal Esophageal Resection for Malignancy
PL16 - Multidisciplinary Approaches and Perioperative Care of Esophagectomy (part 2)
01:30 AM - 03:00 AM
PL16.02 - Detection of Residual Disease After Chemoradiotherapy; Results From Asian Pre-SINO Trial
PL16.03 - Fit For Surgery: Prehabilitation Routine for Esophagectomy
PL16.04 - ERAS Anesthetic Management
PL16.05 - Postop ERAS Protocol for Esophagectomy
David Liu Jessie Elliott Sheraz Markar
YI.01 - Building a Career in Translational Research
YI.02 - Developing Esophageal Clinical Trials in 2022
YI.03 - Creating the Next Generation of Allied Health Professional Researchers
YI.04 - Establishing International Research Collaboratives
PL17 - News on Diagnostics in Esophageal Motility
Arjan Bredenoord Mark Ferguson
PL17.01 - Approach to the Patient With Dysphagia in 2022
PL17.02 - Chicago 4.0: Changes in Definition of EGJOO
PL17.03 - HRM and How to Use Provocation Maneuvers and Consider Adjunct Testing
PL17.04 - Use of Endoflip in Esophageal Diagnostics
PL17.05 - Use of Endoflip in Tailoring Fundoplication and Myotomy
03:00 AM - 03:30 AM
原文链接：http://www.xxwk.net/archives/3397
